User profiles for Panayiota L. Papasavva
Panayiota PapasavvaThe Cyprus Institute of Neurology and Genetics Verified email at cing.ac.cy Cited by 210 |
Distinct miRNA signatures and networks discern fetal from adult erythroid differentiation and primary from immortalized erythroid cells
MicroRNAs (miRNAs) are small non-coding RNAs crucial for post-transcriptional and
translational regulation of cellular and developmental pathways. The study of miRNAs in …
translational regulation of cellular and developmental pathways. The study of miRNAs in …
Context base editing for splice correction of IVSI-110 β-thalassemia
B Naiisseh, PL Papasavva, NY Papaioannou… - … Therapy-Nucleic Acids, 2024 - cell.com
β-Thalassemia is brought about by defective β-globin (HBB [hemoglobin subunit β]) formation
and, in severe cases, requires regular blood transfusion and iron chelation for survival. …
and, in severe cases, requires regular blood transfusion and iron chelation for survival. …
Case report: Rethinking NGS analysis in diagnosing Diamond-Blackfan anemia syndrome
PL Papasavva, K Kaouranis, S Byrou… - Frontiers in …, 2024 - frontiersin.org
Diamond-Blackfan anemia syndrome (DBAS) is a rare inherited bone marrow failure (BMF)
syndrome characterized by erythroid aplasia, congenital malformations, and cancer …
syndrome characterized by erythroid aplasia, congenital malformations, and cancer …
CRISPR editing enables consequential tag-activated MicroRNA-mediated endogene deactivation
PL Papasavva, P Patsali, CC Loucari, R Kurita… - International Journal of …, 2022 - mdpi.com
Molecular therapies and functional studies greatly benefit from spatial and temporal precision
of genetic intervention. We therefore conceived and explored tag-activated microRNA (…
of genetic intervention. We therefore conceived and explored tag-activated microRNA (…
High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis
…, B Naiisseh, PL Papasavva, L Koniali… - Frontiers in Genome …, 2023 - frontiersin.org
Introduction: Genome editing tools, such as CRISPR/Cas, TALE nucleases and, more recently,
double-strand-break-independent editors, have been successfully used for gene therapy …
double-strand-break-independent editors, have been successfully used for gene therapy …
[HTML][HTML] Combining clinical and molecular data for personalized treatment in acute myeloid leukemia: A machine learning approach
N Karathanasis, PL Papasavva, A Oulas… - Computer Methods and …, 2024 - Elsevier
Background and Objective The standard of care in Acute Myeloid Leukemia patients has
remained essentially unchanged for nearly 40 years. Due to the complicated mutational …
remained essentially unchanged for nearly 40 years. Due to the complicated mutational …
Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by HBBAS3 Gene Addition and Mutation-Specific RNA Interference
…, MI Kostopoulou, NY Papaioannou, PL Papasavva… - Cells, 2023 - mdpi.com
Therapy via the gene addition of the anti-sickling β AS3 -globin transgene is potentially curative
for all β-hemoglobinopathies and therefore of particular clinical and commercial interest. …
for all β-hemoglobinopathies and therefore of particular clinical and commercial interest. …
Catching them early: Framework parameters and progress for prenatal and childhood application of advanced therapies
…, L Koniali, T Buerki-Thurnherr, PL Papasavva… - Pharmaceutics, 2022 - mdpi.com
Advanced therapy medicinal products (ATMPs) are medicines for human use based on genes,
cells or tissue engineering. After clear successes in adults, the nascent technology now …
cells or tissue engineering. After clear successes in adults, the nascent technology now …
Deregulated Expression of IL-37 in Patients with Bladder Urothelial Cancer: The Diagnostic Potential of the IL-37e Isoform
M Papasavva, S Amvrosiou, KM Pilala… - International Journal of …, 2023 - mdpi.com
Cellular and molecular immune components play a crucial role in the development and
perpetuation of human malignancies, shaping anti-tumor responses. A novel immune regulator …
perpetuation of human malignancies, shaping anti-tumor responses. A novel immune regulator …
Machine Learning for Predicting Therapeutic Outcomes in Acute Myeloid Leukemia Patients
Background and Objective: The standard of care in Acute Myeloid Leukemia patients has
remained essentially unchanged for nearly 40 years. Due to the complicated mutational …
remained essentially unchanged for nearly 40 years. Due to the complicated mutational …